Evidence map›Paper›PMID 21274892›Full record

ArticleHepatology (Baltimore, Md.)2011

Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come?

Alejandro Soto-Gutierrez, Edgar Tafaleng, Victoria Kelly, Jayanta Roy-Chowdhury, Ira J Fox

Abstract readComment
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Use of stem cells for liver diseases-current scenario.Journal of clinical and experimental hepatology · 2011
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Alejandro Soto-GutierrezCenter for Innovative Regenerative Therapies, Department of Surgery, Transplantation Section, Children's Hospital of Pittsburgh, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Edgar Tafaleng
Victoria Kelly
Jayanta Roy-Chowdhury
Ira J Fox

Funding

CELLULAR ENGINEERING OF HEPATOCYTE CELL LINESR01DK048794 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FOX, IRA J. · 1996 to 2010
$3.1M
Engineering of hepatic grafts with decellularized native matricesR00DK083556 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SOTO-GUTIERREZ, ALEJANDRO · 2011 to 2013
$707k
NIDDK NIH HHS R00 DK083556NIDDK NIH HHS R01 DK048794
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID21274892
PMCPMC3033754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.